Nature Medicine Study Highlights Impact of Doxycycline-Post Exposure Prophylaxis for STI on Gut Microbiome Dr. Bhumika Maikhuri5 Oct 2024 8:00 AM ISTTaking a dose of the oral antibiotic doxycycline after a high-risk sexual encounter has dramatically reduced the incidence of sexually transmitted...
How doxycycline for STI prevention affects the gut microbiome, unravels research Dr. Kamal Kant Kohli4 Oct 2024 10:15 PM ISTTaking a dose of the oral antibiotic doxycycline after a high-risk sexual encounter has dramatically reduced the incidence of sexually transmitted...
Obesity and Diabetes May Be Risk Factors for Recurrence of Hepatocellular Carcinoma, Study Reveals Dr. Bhumika Maikhuri4 Oct 2024 8:00 AM ISTA recent study has highlighted that the coexistence of obesity and Diabetes mellitus increased late recurrence and worsened prognosis in patients with...
Diabetes and obesity tied to Increased risk of liver cancer relapse after resection: Study Dr. Kamal Kant Kohli4 Oct 2024 2:00 AM ISTHepatocellular carcinoma, a type of liver cancer associated with hepatitis infections, is known to have a high recurrence rate after cancer removal....
Pitt study identifies potential new treatment for liver fibrosis Dr. Kamal Kant Kohli2 Oct 2024 8:00 PM ISTNew research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis and suggests a novel...
Alkem Labs Launches Vonzai, the Next Generation Therapy for APD Management Written By Dr. Nandita Mohan1 Oct 2024 11:15 AM ISTAlkem Labs, one of the leaders in the gastro segment with well-known products like PAN, Pan-D, and Obetohep has announced the launch of the...
Gefarnate Enhances Lipid Control in Statin-Treated CAD Patients with High Triglycerides, Study Finds Written By Prem Aggarwal1 Oct 2024 9:00 AM ISTChina: In a randomized controlled trial, researchers have uncovered significant lipid-lowering benefits of gefarnate when added to statin therapy in...
Union Health Ministry Releases Revised Operational Guidelines and Training Manual of NAFLD Dr. Bhumika Maikhuri1 Oct 2024 8:00 AM ISTThe Union Health Ministry released the revised operational guidelines and training manual for non-alcoholic fatty liver disease. According to the...
NEJM: Results from targeted therapy for ulcerative colitis study Dr. Kamal Kant Kohli30 Sept 2024 2:00 AM ISTAn international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai...
Tranexamic acid may help control GI bleeding, prevent rebleeding in cirrhosis patients: Study Written By Dr. Shravani Dali28 Sept 2024 5:30 AM ISTTranexamic acid may help control GI bleeding, and prevent rebleeding in cirrhosis patients suggests a study published in the Hepatology.Patients with...
Major depressive disorder increases risk of irritable bowel syndrome, reveals research Written By Jacinthlyn Sylvia26 Sept 2024 8:45 PM ISTA new study published in the Journal of Affective Disorders demonstrated the causal relationships between major depressive disorder (MDD),...
GLP-1 Receptor Agonists Linked to Lower Risk of Cirrhosis Progression in Early-Stage Metabolic Liver Disease, Study Finds Written By Medha Baranwal23 Sept 2024 8:00 AM ISTUSA: Recent findings from a cohort study have highlighted the potential benefits of GLP-1 receptor agonists (GLP-1 RAs) in managing patients with...
